Table 3.

Secondary outcomes

	EMPA group	Control group	p value	Early DMCMP group	Advanced DMCMP group	p value
NYHA class
12 months	1.3 ± 0.4	1.3 ± 0.5	0.699	1.2 ± 0.4	1.3 ± 0.5	0.755
HbA1c (%)
12 months	7.1 ± 0.7	7.0 ± 0.6	0.473	7.0 ± 0.6	7.2 ± 0.7	0.527
ΔHbA1c	− 1.3 ± 1.5	− 0.9 ± 0.5	0.214	− 1.6 ± 1.5	− 1.0 ± 1.4	0.249
BNP (pg/ml)
12 months	122 (106–165)	168 (127–240)	0.087	113 (106–160)	143 (106–163)	0.605
ΔBNP	− 305 (197–504)	− 302 (188–574)	0.910	− 305 (201–400)	− 398 (143–537)	0.594

Data are means ± SD for normally distributed data and medians and interquartile ranges for non-normally distributed data, or n (%)

All statistical tests were 2-tailed, and p < 0.05 was considered significant (*). Abbreviations as in Table 1